Aaron Wealth Advisors LLC lowered its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 6.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,714 shares of the financial services provider’s stock after selling 274 shares during the quarter. Aaron Wealth Advisors LLC’s holdings in Aflac were worth $384,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also made changes to their positions in AFL. Renaissance Technologies LLC acquired a new stake in shares of Aflac in the 2nd quarter valued at about $10,878,000. Beck Bode LLC increased its holdings in Aflac by 1.3% in the second quarter. Beck Bode LLC now owns 143,350 shares of the financial services provider’s stock valued at $12,803,000 after buying an additional 1,857 shares during the last quarter. Ieq Capital LLC raised its stake in Aflac by 0.5% during the second quarter. Ieq Capital LLC now owns 21,775 shares of the financial services provider’s stock valued at $1,945,000 after buying an additional 101 shares in the last quarter. King Luther Capital Management Corp lifted its holdings in Aflac by 30.7% during the 2nd quarter. King Luther Capital Management Corp now owns 3,600 shares of the financial services provider’s stock worth $322,000 after buying an additional 846 shares during the last quarter. Finally, Thrivent Financial for Lutherans grew its position in shares of Aflac by 7.7% in the 2nd quarter. Thrivent Financial for Lutherans now owns 28,727 shares of the financial services provider’s stock worth $2,566,000 after acquiring an additional 2,051 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.
Aflac Stock Up 0.5 %
Shares of AFL stock opened at $106.43 on Tuesday. Aflac Incorporated has a 1 year low of $75.07 and a 1 year high of $115.50. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.08 and a current ratio of 0.08. The business’s fifty day moving average is $106.41 and its 200-day moving average is $105.47. The stock has a market cap of $59.13 billion, a PE ratio of 16.03, a price-to-earnings-growth ratio of 2.09 and a beta of 1.00.
Aflac Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be issued a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.18%. This is a boost from Aflac’s previous quarterly dividend of $0.50. The ex-dividend date is Wednesday, February 19th. Aflac’s dividend payout ratio (DPR) is presently 30.12%.
Insiders Place Their Bets
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the sale, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.80% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on the stock. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research report on Wednesday, January 8th. Bank of America upped their target price on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Truist Financial boosted their price objective on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Evercore ISI dropped their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research report on Wednesday, December 4th. Finally, TD Cowen initiated coverage on Aflac in a research note on Wednesday, October 9th. They issued a “hold” rating and a $102.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $102.07.
Check Out Our Latest Stock Analysis on AFL
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- CD Calculator: Certificate of Deposit Calculator
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Election Stocks: How Elections Affect the Stock Market
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.